21 January 2025
HSBC Global Funds ICAV
Admission of New Share Classes
The Board of Directors of HSBC Global Funds ICAV plc (the "ICAV") wishes to announce the admission of the following share classes (the "New Share Classes"):
| Sub-Fund Legal Name | Share Class | ISIN | Trade Currency | SEDOL |
| HSBC Global Funds ICAV - Global Sukuk UCITS ETF | ETFS | IE0009U8IBU8 | USD
| BPK3Z31 |
Admission became effective on 17 January 2025.
The investment objective of HSBC Global Funds ICAV - Global Sukuk UCITS ETF (the "Sub-Fund") is to provide regular income and capital growth by tracking as closely as possible the performance of the FTSE IdealRatings Sukuk Index (total return) (the "Index"), while maintaining adherence to Shariah principles.
The admission of the New Share Classes to the Official List and to trading on the London Stock Exchange's main market for listed securities became effective, and dealings commenced 17 January 2025.
Unless otherwise defined herein, all capitalised terms shall bear the same meaning as capitalised terms used in the prospectus of the ICAV dated 17 November 2023 (the "Prospectus").
A copy of the Sub-Fund's supplement have been submitted to the National Storage Mechanism and are available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the ICAV's website at www.assetmanagement.hsbc.com.
Further Information
| HSBC Global Funds ICAV | 3 Dublin Landings, North Wall Quay, Dublin 1 Ireland | +353 1 635 6000* |
| J&E Davy (Sponsor) Brian Garrahy | | +353 1 679 6363* |
|
| | |
| For Media Enquiries Monika Witkowska | HSBC Global Asset Management Monika.witkowska@hsbc.com | +44 203 268 5479* |
* Calls may be recorded
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
